NOVAVAX INC

NVAXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$1.1B

▲ 64.7% YoY

Net Income

$440.3M

▲ 334.8% YoY

EPS

$2.58

▲ 309.8% YoY

Cash

$240.6M

▼ 54.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.